Stephen E Daniels

Summary

Affiliation: SCIREX Corporation
Country: USA

Publications

  1. ncbi Valdecoxib for treatment of primary dysmenorrhea. A randomized, double-blind comparison with placebo and naproxen
    Stephen E Daniels
    SCIREX Corporation, 3200 Red River, Suite 300, Austin, TX 78705, USA
    J Gen Intern Med 20:62-7. 2005
  2. ncbi Rofecoxib 50 mg and valdecoxib 20 or 40 mg in adults and adolescents with postoperative pain after third molar extraction: results of two randomized, double-blind, placebo-controlled, single-dose studies
    Stephen E Daniels
    SCIREX Corporation, Austin, Texas 78705, USA
    Clin Ther 28:1022-34. 2006
  3. ncbi A double-blind randomized controlled trial of rofecoxib and multidose oxycodone/acetaminophen in dental impaction pain
    Paul J Desjardins
    Clinical Research and Clinical Site Operations, SCIREX Clinical Research Centers, Austin, TX 78705, USA
    J Oral Maxillofac Surg 65:1624-32. 2007
  4. ncbi Valdecoxib, a cyclooxygenase-2-specific inhibitor, is effective in treating primary dysmenorrhea
    Stephen E Daniels
    From the Scirex Corporation, Austin, Texas, USA
    Obstet Gynecol 100:350-8. 2002
  5. ncbi The analgesic efficacy of valdecoxib vs. oxycodone/acetaminophen after oral surgery
    Stephen E Daniels
    Clinical Site Operations, SCIREX Corp, Austin, Texas, USA
    J Am Dent Assoc 133:611-21; quiz 625. 2002
  6. ncbi Evaluation of the dose range of etoricoxib in an acute pain setting using the postoperative dental pain model
    Stephen E Daniels
    Premier Research Group, 3200 Red River Boulevard, Austin, TX 78705, USA
    Clin J Pain 27:1-8. 2011
  7. ncbi A randomised, five-parallel-group, placebo-controlled trial comparing the efficacy and tolerability of analgesic combinations including a novel single-tablet combination of ibuprofen/paracetamol for postoperative dental pain
    Stephen E Daniels
    Premier Research, Austin, TX 78705, USA
    Pain 152:632-42. 2011
  8. ncbi A phase 3, randomized, placebo-controlled trial of DepoFoam® bupivacaine (extended-release bupivacaine local analgesic) in bunionectomy
    Michael Golf
    Premier Clinical Research Centers, Austin, TX, USA
    Adv Ther 28:776-88. 2011
  9. ncbi Clinical efficacy and safety of tapentadol immediate release in the postoperative setting
    Stephen E Daniels
    Premier Research Group, Austin, TX, USA
    J Am Podiatr Med Assoc 102:139-48. 2012
  10. ncbi A randomized, double-blind, phase III study comparing multiple doses of tapentadol IR, oxycodone IR, and placebo for postoperative (bunionectomy) pain
    Stephen E Daniels
    Premier Research, Austin, TX, USA
    Curr Med Res Opin 25:765-76. 2009

Detail Information

Publications13

  1. ncbi Valdecoxib for treatment of primary dysmenorrhea. A randomized, double-blind comparison with placebo and naproxen
    Stephen E Daniels
    SCIREX Corporation, 3200 Red River, Suite 300, Austin, TX 78705, USA
    J Gen Intern Med 20:62-7. 2005
    ..To compare the analgesic efficacy of valdecoxib with placebo and naproxen sodium for relieving menstrual cramping and pain due to primary dysmenorrhea...
  2. ncbi Rofecoxib 50 mg and valdecoxib 20 or 40 mg in adults and adolescents with postoperative pain after third molar extraction: results of two randomized, double-blind, placebo-controlled, single-dose studies
    Stephen E Daniels
    SCIREX Corporation, Austin, Texas 78705, USA
    Clin Ther 28:1022-34. 2006
    ..These studies assessed the comparative efficacy of rofecoxib and valdecoxib in the treatment of acute postoperative dental pain...
  3. ncbi A double-blind randomized controlled trial of rofecoxib and multidose oxycodone/acetaminophen in dental impaction pain
    Paul J Desjardins
    Clinical Research and Clinical Site Operations, SCIREX Clinical Research Centers, Austin, TX 78705, USA
    J Oral Maxillofac Surg 65:1624-32. 2007
  4. ncbi Valdecoxib, a cyclooxygenase-2-specific inhibitor, is effective in treating primary dysmenorrhea
    Stephen E Daniels
    From the Scirex Corporation, Austin, Texas, USA
    Obstet Gynecol 100:350-8. 2002
    ..Valdecoxib 20 mg and 40 mg demonstrate analgesic efficacy, based on onset, magnitude, and duration of analgesia that is similar to naproxen sodium, making it a potential choice for treating women with primary dysmenorrhea...
  5. ncbi The analgesic efficacy of valdecoxib vs. oxycodone/acetaminophen after oral surgery
    Stephen E Daniels
    Clinical Site Operations, SCIREX Corp, Austin, Texas, USA
    J Am Dent Assoc 133:611-21; quiz 625. 2002
    ..The studies reported here suggest that the COX-2-specific inhibitor valdecoxib offers an efficacious and safe alternative to other analgesics used to treat pain after oral surgery...
  6. ncbi Evaluation of the dose range of etoricoxib in an acute pain setting using the postoperative dental pain model
    Stephen E Daniels
    Premier Research Group, 3200 Red River Boulevard, Austin, TX 78705, USA
    Clin J Pain 27:1-8. 2011
    ..This study was conducted to evaluate the dose range of etoricoxib in acute pain using the postoperative dental pain model further...
  7. ncbi A randomised, five-parallel-group, placebo-controlled trial comparing the efficacy and tolerability of analgesic combinations including a novel single-tablet combination of ibuprofen/paracetamol for postoperative dental pain
    Stephen E Daniels
    Premier Research, Austin, TX 78705, USA
    Pain 152:632-42. 2011
    ..A single-tablet combination of ibuprofen 200mg/paracetamol 500mg provides highly effective analgesia, comparable or superior to other combination analgesics indicated for strong pain...
  8. ncbi A phase 3, randomized, placebo-controlled trial of DepoFoam® bupivacaine (extended-release bupivacaine local analgesic) in bunionectomy
    Michael Golf
    Premier Clinical Research Centers, Austin, TX, USA
    Adv Ther 28:776-88. 2011
    ..San Diego, CA, USA), an extended-release liposomal bupivacaine-based analgesic, was compared with placebo for the prevention of pain after bunionectomy in a randomized, multicenter, double-blind phase 3 clinical study...
  9. ncbi Clinical efficacy and safety of tapentadol immediate release in the postoperative setting
    Stephen E Daniels
    Premier Research Group, Austin, TX, USA
    J Am Podiatr Med Assoc 102:139-48. 2012
    ..Therefore, tapentadol immediate release may offer an improved analgesic option for the relief of postoperative pain after podiatric surgery...
  10. ncbi A randomized, double-blind, phase III study comparing multiple doses of tapentadol IR, oxycodone IR, and placebo for postoperative (bunionectomy) pain
    Stephen E Daniels
    Premier Research, Austin, TX, USA
    Curr Med Res Opin 25:765-76. 2009
    ..This study evaluated tapentadol immediate release (IR) for pain relief following orthopedic bunionectomy surgery...
  11. ncbi An assessment of the efficacy and safety of diclofenac potassium liquid-filled capsules in patients with various levels of baseline pain intensity
    Stephen E Daniels
    Premier Research Group Ltd, Austin, TX 78666, USA
    Curr Med Res Opin 28:953-61. 2012
    ..Diclofenac potassium liquid-filled soft gelatin capsule (DPSGC; Zipsor*) is a novel formulation of diclofenac potassium used to treat mild to moderate acute pain...
  12. ncbi Efficacy and safety of oxycodone HCl/niacin tablets for the treatment of moderate-to-severe postoperative pain following bunionectomy surgery
    Stephen E Daniels
    Premier Research Group, Austin, Texas 78705, USA
    Curr Med Res Opin 27:593-603. 2011
    ..To evaluate the efficacy and safety of two dose strengths of oxycodone hydrochloride (HCl)/niacin tablets * for the treatment of moderate-to-severe postoperative pain following bunionectomy surgery...
  13. ncbi A randomized, double-blind, celecoxib- and placebo-controlled study of the effectiveness of CS-706 in acute postoperative dental pain
    James B Moberly
    Daiichi Sankyo Pharma Development, Edison, New Jersey 08837, USA
    Clin Ther 29:399-412. 2007
    ..CS-706 is a cyclooxygenase-2 (COX-2)-selective inhibitor with an in vitro selectivity ratio (COX-1:COX-2) similar to that of celecoxib. It has exhibited analgesic, anti-inflammatory, and antitumor properties in animal models...